Skip to main content

Table 1 Clinical characteristics and tumor parameters of patients according to LCT 13910 C/T and CaSR A986S genotypes

From: Effects of the lactase 13910 C/T and calcium-sensor receptor A986S G/T gene polymorphisms on the incidence and recurrence of colorectal cancer in Hungarian population

 

LCT 13910 C/T genotypes

CaSR A986S genotypes

 

TT + TC

(n = 125)

CC

(n = 90)

p value

AA + AS

(n = 200)

SS

(n = 15)

p value

Age at the diagnosis (year) (mean ± SD)

60 ± 11

61 ± 10

0.54

61 ± 10

62 ± 13

0.64

Male/female (case number)

66/59

54/36

0.29

112/88

8/7

0.84

Tumor location (case number)

  

0.71a

  

0.40a

   Rectum

69

52

 

111

10

 

   Left colon

27

17

 

41

3

 

   Right colon

29

21

 

48

2

 

TNM classification (case number)

      

   T1

0

2

0.54b

2

0

0.22b

   T2

25

13

 

37

1

 

   T3

74

60

 

125

9

 

   T4

26

15

 

36

5

 

   N0

36

25

0.87c

54

7

0.10c

   N1

58

43

 

96

5

 

   N2

31

22

 

50

3

 

   M0

88

66

0.49

143

11

0.88

   M1

38

23

 

57

4

 

AJCC stages (case number)

  

0.87d

  

0.10d

   I

10

6

 

15

1

 

   IIA

13

10

 

20

3

 

   IIB

13

9

 

19

3

 

   IIIA

9

4

 

13

0

 

   IIIB

26

20

 

44

2

 

   IIIC

16

18

 

32

2

 

   IV

38

23

 

57

4

 

Serum calcium (mmol/L), (mean ± SD)

2.39 ± 0.12

2.39 ± 0.11

0.85

2.39 ± 0.11

2.39 ± 0.16

0.91

   Normal range (2.2–2.6)

      

   Female

2.41 ± 0.11

2.36 ± 0.14

0.038e

2.39 ± 0.11

2.43 ± 0.18

0.42

   Male

2.37 ± 0.12

2.39 ± 0.11

0.23

2.39 ± 0.11

2.35 ± 0.15

0.37

Adjusted serum calcium (mmol/L), (mean ± SD)

2.30 ± 0.11

2.30 ± 0.13

0.89

2.29 ± 0.11

2.35 ± 0.17

0.13

   Normal range (2.09–2.54)

      

   Female

2.31 ± 0.12

2.29 ± 0.11

0.31

2.29 ± 0.11

2.40 ± 0.19

0.036e

   Male

2.29 ± 0.10

2.31 ± 0.14

0.54

2.29 ± 0.12

2.31 ± 0.14

0.89

Serum CEA (ng/mL), [median (interquartile range)]

3.33(25.16)

3.41(13.61)

0.79

3.34(16.13)

3.01(90.77)

0.89

   Normal range (< 4.3)

      

Serum CA19-9 (U/mL), [median (interquartile range)]

11.15(92.09)

7.21(26.53)

0.59

9.77(42.66)

6.88(214.75)

0.98

   Normal range (< 39)

      

Serum AFP (ng/mL), [median (interquartile range)]

3.81(2.23)

3.43(3.05)

0.58

3.57(2.33)

3.57(6.52)

0.94

   Normal range (< 13.6)

      
  1. aP value designates the association for rectum vs. other tumor site
  2. bP value designates the association for T1+T2 vs. T3+T4 stages
  3. cP value designates the association for N0 vs. N1+N2 stages
  4. dP value designates the association for I-II vs. III-IV stages
  5. eThe association did not remain significant after adjusting for multiple testing
  6. Detailed data were available only for 215 CRC patients